Literature DB >> 19151931

Mild IVF using GnRH agonist long protocol is possible: comparing stimulations with 100 IU vs. 150 IU recombinant FSH as starting dose.

Sylvia Fernández-Shaw1, Nuria Pérez Esturo, Rosa Cercas Duque, Isabel Pons Mallol.   

Abstract

PURPOSE: To test the possibility of stimulating ovaries with a mild IVF approach using a GnRH agonist long protocol.
METHODS: Retrospective study of 142 first IVF cycles of women aged 30 to 35 who had undergone stimulation with 100 IU or 150 IU of rFSH.
RESULTS: The mean dose of rFSH used was smaller in the low dose compared with the high dose group (999 vs. 1343 IU; p<0.001), obtaining comparable numbers of mature oocytes in both groups. Additionally, reducing the mean number of embryos transferred from 1.8 to 1.5 significantly decreased the twin rate in the low dose group while maintaining similar pregnancy rates in both groups.
CONCLUSIONS: It is possible to develop mild IVF using GnRH agonist long protocol in women with good prognosis. A reduced amount of rFSH and fewer transferred embryos allow for lower costs and risks of IVF without compromising the pregnancy rate.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19151931      PMCID: PMC2654940          DOI: 10.1007/s10815-008-9289-z

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  29 in total

Review 1.  Impact of ovarian stimulation on corpus luteum function and embryonic implantation.

Authors:  A Tavaniotou; C Albano; J Smitz; P Devroey
Journal:  J Reprod Immunol       Date:  2002 May-Jun       Impact factor: 4.054

2.  A randomized, double-blind, multicentre clinical trial comparing starting doses of 150 and 200 IU of recombinant FSH in women treated with the GnRH antagonist ganirelix for assisted reproduction.

Authors:  Henk J Out; Anthony Rutherford; Richard Fleming; Clement C K Tay; Geoffrey Trew; William Ledger; David Cahill
Journal:  Hum Reprod       Date:  2004-01       Impact factor: 6.918

3.  The role of estrogen in uterine receptivity and blastocyst implantation.

Authors:  Carlos Simon; Francisco Domínguez; Diana Valbuena; Antonio Pellicer
Journal:  Trends Endocrinol Metab       Date:  2003-07       Impact factor: 12.015

Review 4.  Reproductive biology and IVF: ovarian stimulation and endometrial receptivity.

Authors:  Paul Devroey; Claire Bourgain; Nicholas S Macklon; Bart C J M Fauser
Journal:  Trends Endocrinol Metab       Date:  2004-03       Impact factor: 12.015

5.  Embryo implantation after human in vitro fertilization: importance of endometrial receptivity.

Authors:  R J Paulson; M V Sauer; R A Lobo
Journal:  Fertil Steril       Date:  1990-05       Impact factor: 7.329

6.  The luteal phase of cycles utilizing controlled ovarian hyperstimulation and the possible impact of this hyperstimulation on embryo implantation.

Authors:  B A Kolb; R J Paulson
Journal:  Am J Obstet Gynecol       Date:  1997-06       Impact factor: 8.661

7.  Dose of human menopausal gonadotropin influences the outcome of an in vitro fertilization program.

Authors:  Z Ben-Rafael; C A Benadiva; M Ausmanas; B Barber; L Blasco; G L Flickinger; L Mastroianni
Journal:  Fertil Steril       Date:  1987-12       Impact factor: 7.329

8.  Uterine endometrial peristalsis--a transvaginal ultrasound study.

Authors:  J S Abramowicz; D F Archer
Journal:  Fertil Steril       Date:  1990-09       Impact factor: 7.329

9.  The clinical efficacy and efficiency of a 100-IU starting dose of recombinant follicle stimulating hormone (Puregon) in Korean women undergoing in vitro fertilization and embryo transfer.

Authors:  Shin Yong Moon; Seok Hyun Kim; Seung Yup Ku; Byoung Chul Jee; Young Min Choi; Jin Yong Lee
Journal:  J Obstet Gynaecol Res       Date:  2003-06       Impact factor: 1.730

10.  Morphological and cytogenetic analysis of human giant oocytes and giant embryos.

Authors:  Hanna Balakier; Derek Bouman; Agata Sojecki; Clifford Librach; Jeremy A Squire
Journal:  Hum Reprod       Date:  2002-09       Impact factor: 6.918

View more
  3 in total

1.  MILD ovarian stimulation with GnRH-antagonist vs. long protocol with low dose FSH for non-PCO high responders undergoing IVF: a prospective, randomized study including thawing cycles.

Authors:  Simona Casano; Daniela Guidetti; Ambra Patriarca; Giulia Pittatore; Gianluca Gennarelli; Alberto Revelli
Journal:  J Assist Reprod Genet       Date:  2012-10-20       Impact factor: 3.412

Review 2.  Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization.

Authors:  Alberto Revelli; Simona Casano; Francesca Salvagno; Luisa Delle Piane
Journal:  Reprod Biol Endocrinol       Date:  2011-02-16       Impact factor: 5.211

3.  Mild starting dosage ovarian stimulation combined with a modified prolonged GnRH-a protocol improved IVF/ICSI outcomes in normal ovarian responders.

Authors:  Li-Feng Tian; Jun Tan; Yang Zou; Qiong Su; You Li; Ding-Fei Xu; Qiong-Fang Wu
Journal:  Arch Med Sci       Date:  2019-05-16       Impact factor: 3.318

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.